1. Home
  2. EDIT vs GOCO Comparison

EDIT vs GOCO Comparison

Compare EDIT & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • GOCO
  • Stock Information
  • Founded
  • EDIT 2013
  • GOCO 2001
  • Country
  • EDIT United States
  • GOCO United States
  • Employees
  • EDIT N/A
  • GOCO N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • GOCO Specialty Insurers
  • Sector
  • EDIT Health Care
  • GOCO Finance
  • Exchange
  • EDIT Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • EDIT 115.5M
  • GOCO 111.2M
  • IPO Year
  • EDIT 2016
  • GOCO 2020
  • Fundamental
  • Price
  • EDIT $1.79
  • GOCO $5.53
  • Analyst Decision
  • EDIT Buy
  • GOCO Hold
  • Analyst Count
  • EDIT 13
  • GOCO 1
  • Target Price
  • EDIT $6.73
  • GOCO $18.00
  • AVG Volume (30 Days)
  • EDIT 1.9M
  • GOCO 68.1K
  • Earning Date
  • EDIT 05-12-2025
  • GOCO 05-13-2025
  • Dividend Yield
  • EDIT N/A
  • GOCO N/A
  • EPS Growth
  • EDIT N/A
  • GOCO N/A
  • EPS
  • EDIT N/A
  • GOCO N/A
  • Revenue
  • EDIT $35,837,000.00
  • GOCO $834,266,000.00
  • Revenue This Year
  • EDIT N/A
  • GOCO $8.15
  • Revenue Next Year
  • EDIT N/A
  • GOCO $6.05
  • P/E Ratio
  • EDIT N/A
  • GOCO N/A
  • Revenue Growth
  • EDIT N/A
  • GOCO 13.18
  • 52 Week Low
  • EDIT $0.91
  • GOCO $5.51
  • 52 Week High
  • EDIT $6.22
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 60.00
  • GOCO 25.69
  • Support Level
  • EDIT $1.70
  • GOCO $5.57
  • Resistance Level
  • EDIT $1.95
  • GOCO $6.70
  • Average True Range (ATR)
  • EDIT 0.15
  • GOCO 0.55
  • MACD
  • EDIT 0.03
  • GOCO 0.00
  • Stochastic Oscillator
  • EDIT 76.03
  • GOCO 1.49

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: